CN112823039A - 用于治疗和预防皮肤衰老和光老化的肽 - Google Patents

用于治疗和预防皮肤衰老和光老化的肽 Download PDF

Info

Publication number
CN112823039A
CN112823039A CN201980066612.1A CN201980066612A CN112823039A CN 112823039 A CN112823039 A CN 112823039A CN 201980066612 A CN201980066612 A CN 201980066612A CN 112823039 A CN112823039 A CN 112823039A
Authority
CN
China
Prior art keywords
peptide
use according
seq
skin
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980066612.1A
Other languages
English (en)
Chinese (zh)
Inventor
P·佩莱格里尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rome United Chemical Center Co Ltd Abbreviated C4t Co ltd AS
Original Assignee
Rome United Chemical Center Co Ltd Abbreviated C4t Co ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rome United Chemical Center Co Ltd Abbreviated C4t Co ltd AS filed Critical Rome United Chemical Center Co Ltd Abbreviated C4t Co ltd AS
Publication of CN112823039A publication Critical patent/CN112823039A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201980066612.1A 2018-10-11 2019-10-10 用于治疗和预防皮肤衰老和光老化的肽 Pending CN112823039A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102018000009384 2018-10-11
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Publications (1)

Publication Number Publication Date
CN112823039A true CN112823039A (zh) 2021-05-18

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980066612.1A Pending CN112823039A (zh) 2018-10-11 2019-10-10 用于治疗和预防皮肤衰老和光老化的肽

Country Status (13)

Country Link
US (1) US20210395305A1 (cg-RX-API-DMAC7.html)
EP (1) EP3863728B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022508676A (cg-RX-API-DMAC7.html)
KR (1) KR20210075098A (cg-RX-API-DMAC7.html)
CN (1) CN112823039A (cg-RX-API-DMAC7.html)
AU (1) AU2019357261A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021006742A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115025A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190888A1 (cg-RX-API-DMAC7.html)
IL (1) IL282064B (cg-RX-API-DMAC7.html)
IT (1) IT201800009384A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202103026YA (cg-RX-API-DMAC7.html)
WO (1) WO2020075108A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115400129A (zh) * 2021-05-28 2022-11-29 株式会社Lg生活健康 细胞衰老表型改变用或皮肤老化防止用组合物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR102726837B1 (ko) * 2021-09-29 2024-11-07 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102774179B1 (ko) * 2021-09-29 2025-03-04 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102877905B1 (ko) * 2021-09-30 2025-10-30 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102736940B1 (ko) * 2021-09-30 2024-12-03 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
WO1999039728A2 (en) * 1998-02-04 1999-08-12 Trustees Of Boston University Methods of inducing hair growth and coloration
US6029114A (en) * 1996-07-31 2000-02-22 Queen's University At Kingston Molecular modelling of neurotrophin-receptor binding
US20140242007A1 (en) * 2011-11-02 2014-08-28 Biomed Venture S.R.L. Societa Unipersonale Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
CN107286233A (zh) * 2016-04-13 2017-10-24 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848A (zh) * 2017-12-28 2018-05-01 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US6919426B2 (en) 2002-09-19 2005-07-19 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
UA97086C2 (uk) 2003-07-15 2012-01-10 Емджен, Інк. Виділене людське антитіло, яке специфічно зв'язується з фактором росту нервової тканини (ngf)
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
MX2009010757A (es) * 2007-04-06 2010-02-24 Kai Pharmaceuticals Inc Metodos de uso de compuestos de inhibidor gamma para atenuacion del dolor.
IT1394690B1 (it) * 2008-10-23 2012-07-13 Carli De Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf.
KR101520333B1 (ko) * 2008-11-25 2015-05-14 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
KR20130031247A (ko) 2010-03-17 2013-03-28 애보트 리서치 비.브이. 항―신경 성장 인자（ｎｇｆ） 항체 조성물
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
FR2961814B1 (fr) * 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
CA2818610C (en) * 2010-11-18 2020-02-18 Steven Yoelin Compositions and methods for hair growth
BR112018005587A8 (pt) * 2015-09-22 2022-08-09 Currahee Holding Company Inc Métodos para aprimorar a aplicação tópica de um agente de benefício básico
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6029114A (en) * 1996-07-31 2000-02-22 Queen's University At Kingston Molecular modelling of neurotrophin-receptor binding
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
WO1999039728A2 (en) * 1998-02-04 1999-08-12 Trustees Of Boston University Methods of inducing hair growth and coloration
US20140242007A1 (en) * 2011-11-02 2014-08-28 Biomed Venture S.R.L. Societa Unipersonale Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
CN107286233A (zh) * 2016-04-13 2017-10-24 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848A (zh) * 2017-12-28 2018-05-01 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALESSIO TRAVAGLIA ET AL.: "A Small Linear Peptide Encompassing the NGF N-Terminus Partly Mimics the Biological Activities of the Entire Neurotrophin in PC12 Cells", 《ACS CHEMICAL NEUROSCIENCE》, vol. 6, pages 1379 - 1392 *
FRANCESCA STANZIONE ET AL.: "Role of the Conformational Versatility of the Neurotrophin N-Terminal Regions in Their Recognition by Trk Receptors", 《BIOPHYSICAL JOURNAL》, vol. 99, pages 2273 - 2278, XP055281247, DOI: 10.1016/j.bpj.2010.07.054 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115400129A (zh) * 2021-05-28 2022-11-29 株式会社Lg生活健康 细胞衰老表型改变用或皮肤老化防止用组合物

Also Published As

Publication number Publication date
US20210395305A1 (en) 2021-12-23
JP2022508676A (ja) 2022-01-19
WO2020075108A1 (en) 2020-04-16
IT201800009384A1 (it) 2020-04-11
KR20210075098A (ko) 2021-06-22
BR112021006742A2 (pt) 2021-09-21
AU2019357261A1 (en) 2021-05-13
EP3863728B1 (en) 2026-07-15
EP3863728A1 (en) 2021-08-18
SG11202103026YA (en) 2021-04-29
EA202190888A1 (ru) 2021-07-07
IL282064B (en) 2022-09-01
IL282064A (en) 2021-05-31
CA3115025A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
US20210395305A1 (en) Peptide for cosmetic application
KR101830926B1 (ko) 피부 노화를 방지 및/또는 개선하기 위해 사용되는 pedf-유도 폴리펩티드의 용도
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
CN109563132B (zh) 皮肤再生或伤口治疗用的肽及其用途
US9567368B2 (en) Peptide tyrosinase activators
CN107080831A (zh) 短抗微生物脂肽
US8962565B2 (en) Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same
US20100261658A1 (en) Peptide for activating aquaporin synthesis
JP7854982B2 (ja) 皮膚科領域における治療用途のためのペプチド
US20170239161A1 (en) Peptide, method and composition for stimulating melanogenesis
TWI634123B (zh) 刺激黑色素生成的胜肽、方法及組合物
US8304392B2 (en) Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
JP6300329B2 (ja) 角質層内で発現されるポリペプチドおよびその使用
JP5827958B2 (ja) 新規カスパーゼ−１４活性化ペプチドおよびそれを含む組成物
US20040043463A1 (en) Peptide-tagged proteins and compositions for regulating features of the skin or hair; methods of making, and methods of using thereof
US5719126A (en) Melanogenic inhibitor, and methods of producing and using the same
US9814663B2 (en) Peptide, method and composition for inhibiting melanogenesis
TWI614022B (zh) 降低黑色素含量的胜肽、方法及組合物
US9566222B2 (en) Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof
US9107852B2 (en) Uses of agonists of delta opioid receptor in cosmetic and dermocosmetic field
EP3242724A1 (en) R-spondin agonist-mediated hair growth
GB2576705A (en) Improvements in or relating to organic material

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210518

WD01 Invention patent application deemed withdrawn after publication